Should Investors Avoid Rigetti Computing as It Struggles to Generate Revenue?

Revenue fell 17% to $1.9M in the quarter, missing the $2.3M consensus; gross margin compressed to 35% from 44% (‑900bps), operating expenses rose 19% to $23.2M, producing an operating loss of $22.6M and an adjusted net loss of $11.3M ($0.03/sh). Rigetti delayed shipments of its Cepheus‑1 108‑qubit system and now expects 99.5% median two‑qubit gate fidelity later this month; it reports 99.9% two‑qubit fidelity that trails peers (IonQ ~99.99%). Despite recent orders (two Novera systems for $5.7M and an $8.4M CDAC order) and a projected 2026 revenue near $20M, the company trades at a market cap >$5B, leading to a recommendation to avoid the stock given weak fundamentals and competitive lag.

Analysis

Market pricing currently treats the company as a pure-option on future quantum dominance rather than a cash-flowing business, which creates a fragile valuation profile: any operational miss or delay will mechanically compress value far faster than fundamentals can recover. That fragility amplifies second-order pressure on the supply chain (control electronics, dilution refrigeration vendors, and integration services) because orders are lumpy and tied to successful deployments — vendors will face volatile revenue recognition and higher working-capital needs as customers wait for demonstrable fidelity improvements.

Competitive dynamics favor incumbents that can credibly deliver repeatable, audited gate fidelity and enterprise SLAs; constrained suppliers and alternative qubit modalities (trapped-ion vendors) stand to win incremental share if customers prioritize lower error rates over sheer qubit count. Sentiment-driven holders create a path-dependent unwind risk: a single failed deployment or missed benchmark can trigger algorithmic selling and retail exodus, widening the gap between narrative and fundamentals.

Key catalysts to watch are independent benchmark releases, certified customer integrations, and the timeline for any capital raises — these set the binary outcomes over days-to-weeks (news shocks) and months (deployments translating to bookings). Tail risks include rapid dilution, tech obsolescence from a competitor fidelity breakthrough, or a strategic acquisition that re-rates value — any of which can meaningfully swing returns for equity and option holders.

A pragmatic contrarian: the market may be overstating ultimate failure risk while understating the value of a retainable IP stack and services pipeline; a small, tactical asymmetric position captures downside while keeping optionality for upside from M&A or credible roadmap delivery.

Key Decisions for Investors

• Initiate a tactical short on RGTI equity (size 0.25% of fund NAV) with a 3–12 month horizon. Rationale: narrative-sensitive valuation with operational execution risk. Risk management: stop-loss at 30% adverse move; target 40–70% downside if milestones slip or a dilutive financing occurs.
• Pair trade: Short RGTI / Long IONQ (1:1 notional) for 3–12 months to isolate winner-takes-share dynamics in fidelity-sensitive procurement. Rationale: isolates technology merit; risk/reward asymmetry favors IonQ if independent benchmarks continue to diverge. Close if spread tightens by >30% or after next major certification cycle.
• Buy a defined-risk put spread on RGTI to hedge directional downside: buy 3–6 month put spread approximately 20–30% OTM (buy lower strike, sell further OTM) sized to 0.1–0.2% fund NAV. Rationale: caps premium while offering 3–6x payoff on a negative surprise; max loss = premium paid.
• Long selective exposure to NVDA (buy 6–12 month call spreads or outright long) as a convex hedge to system-level compute demand and potential quantum control hardware acceleration. Size: 0.25–0.5% NAV. Rationale: hedges market rally in advanced compute; exit on 20–30% profit or fundamental shift in AI/compute demand.